Previous close | 159.02 |
Open | 0.00 |
Bid | 143.13 x 0 |
Ask | 174.91 x 0 |
Day's range | 159.02 - 159.02 |
52-week range | 159.02 - 168.29 |
Volume | |
Avg. volume | 0 |
Market cap | 383.203B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 29.83 |
EPS (TTM) | 5.33 |
Earnings date | 17 July 2024 |
Forward dividend & yield | 4.76 (2.99%) |
Ex-dividend date | 20 May 2024 |
1y target est | N/A |
Many Johnson & Johnson ( NYSE:JNJ ) insiders ditched their stock over the past year, which may be of interest to the...
J&J is doubling down on medtech, a typically sleepy sector that has been risky, as it looks to grow after spinning of consumer health segment Kenvue.
NEW BRUNSWICK, N.J., April 16, 2024--In the section titled "Full-Year 2024 Guidance", in the table, row titled "Operational Sales2,5/ Mid-point", the numbers for the April 2024 column should read: $88.7B – $89.1B / $88.9B (instead of: $88.7B – $89.1B / $88.0B).